Sigma-tau BV is the Dutch subsidiary of the international pharmaceutical group sigma-tau, one of the leading Italian players in the pharmaceutical industry. Sigma-tau has a strong international presence and is part of the Alfasigma Group.
Our objective is: a better human health. To achieve this goal we develop medicines and dietary supplements that help to improve our patients quality of life.
On this website you will find key information about our business, together with useful information about our products.
We are convinced that our future will be innovation-based. Research, which is the major driver of innovation, must be efficient and should receive constant support.
In its latest research, sigma-tau focused on a number of key areas. One area concerns studies with carnitene – a natural substance which is particularly suitable for correcting the biochemical and metabolic defects that cause various conditions. A second headline of research relates to the company's involvement in therapeutic areas where it has specific knowledge, such as cardiovascular, metabolic and central nervous system disorders.
In addition sigma-tau, in cooperation with the non-profit Medicines for Malaria Venture (MMV), has embarked on a project aimed at obtaining international marketing authorization for the treatment of malaria. Here we have been applying our own knowledge of the industry in an effort to make this drug available in countries where millions are still falling victim to this disease.
If you take any medication of sigma-tau BV and experience an adverse event, you can report this by filling in the fields on the right side of this page – even if you are uncertain whether it really is an adverse event.
Reporting of an adverse event is important. In doing so you are helping to keep knowledge about the safety of medicines up to date.
If you would like to contact sigma-tau BV for some other reason, click here
Your information will always be treated confidentially and anonymously. It will not be used for commercial purposes.